UBS Group’s CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM NPD Stock Holding History

UBS Group’s Portfolio NPD Stock Details NPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,074	Closed	-$8K	–	8312
2016 Q2	$8K	Sell	3,074 -6,514	-68%	-$16K	﹤0.01%	6946
2016 Q1	$24K	Sell	9,588 -917	-9%	-$2.13K	﹤0.01%	6079
2015 Q4	$26K	Buy	10,505 +7,487	+248%	+$17.7K	﹤0.01%	6492
2015 Q3	$6K	Buy	3,018 +686	+29%	+$1.5K	﹤0.01%	7658
2015 Q2	$5K	Buy	+2,332	New	+$6K	﹤0.01%	7920
2015 Q1	–	Sell	-3,037	Closed	-$5K	–	9879
2014 Q4	$5K	Buy	+3,037	New	+$5.16K	﹤0.01%	9055

UBS Group's NPD Position: Q3 2016 in Review

UBS Group sold out of CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM (NPD) in Q3 2016, closing a stake of 3,074 shares — an estimated $8K sold.

UBS Group first reported a position in NPD in Q4 2014 and held it in 6 quarters. The position peaked at $26K in Q4 2015. 0 funds tracked by Wall St. Rank hold NPD as of Q3 2016.

UBS Group reported no remaining CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM position as of Q3 2016 after selling out during the quarter.
UBS Group sold 3,074 CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM shares in Q3 2016, an estimated $8K.
UBS Group first reported a position in CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM in Q4 2014 and held it in 6 quarters.
UBS Group's CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM position peaked at $26K in Q4 2015.
0 funds tracked by Wall St. Rank held CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM as of Q3 2016.

Based on UBS Group's 13F filing for Q3 2016, filed 14 Nov 2016.